Your browser doesn't support javascript.
loading
Post-antibiotic growth suppression of linezolid against Gram-positive bacteria.
Munckhof, W J; Giles, C; Turnidge, J D.
Afiliación
  • Munckhof WJ; Department of Infectious Diseases, Infection Control and Sexual Health, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, Queensland 4102, Australia. wendy_munckhof@health.qld.gov.au
J Antimicrob Chemother ; 47(6): 879-83, 2001 Jun.
Article en En | MEDLINE | ID: mdl-11389123
ABSTRACT
The in vitro post-antibiotic effects (PAEs) of eight different concentrations of linezolid against Gram-positive cocci were investigated and the results analysed using the sigmoid E(max) model for mathematically modelling the PAE. Mean maximal linezolid PAEs against strains of Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Enterococcus faecium and Streptococcus pneumoniae were 2.2, 1.8, 2.8, 2.0 and 3.0 h, respectively. Resistance to methicillin (for the staphylococci), vancomycin (for the enterococci) and penicillin (for the pneumococci) had no effect on the duration of the PAE. Results of PAE testing support twice-daily dosing of linezolid in humans.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxazolidinonas / Bacterias Grampositivas / Acetamidas / Antibacterianos Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2001 Tipo del documento: Article País de afiliación: Australia
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oxazolidinonas / Bacterias Grampositivas / Acetamidas / Antibacterianos Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2001 Tipo del documento: Article País de afiliación: Australia